-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Challenges in Operationalizing Decentralized Clinical Trials: The Institutional Perspective

Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Implementation of Decentralized Clinical Trials
Friday, December 6, 2024, 3:04 PM-3:51 PM

Irene Ghobrial, MD

Dana-Farber Cancer Institute, Boston, MA

Disclosures: Ghobrial: AbbVie: Consultancy; Adaptive: Consultancy; Aptitude Health: Consultancy; Bristol Myers Squibb: Consultancy, Other: Speaker fees; Novartis: Consultancy; GlaxoSmithKline: Consultancy; Huron Consulting: Consultancy; Janssen: Consultancy, Other: Speaker fees; Menarini Silicon Biosystems: Consultancy, Other: Speaker fees; Oncopeptides: Consultancy; Pfizer: Consultancy, Other: Speaker fees; Sanofi: Consultancy; Takeda: Consultancy, Other: Speaker fees; Regeneron: Consultancy, Other: Speaker fees; Binding Site, part of Thermo Fisher Scientific: Consultancy; CurioScience: Consultancy, Other: Speaker fees; Window Therapeutics: Consultancy; 10X Genomics: Consultancy; Vor Biopharma: Other: Speaker fees; Standard Biotools: Other: Speaker fees; Amgen: Consultancy, Other: Speaker fees; PreDICTA Bioscience: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Other: Co-founder; Disc Medicine: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees.